Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 July 2024
Human medicines European public assessment report (EPAR): Invega, paliperidone, Date of authorisation: 24/06/2007, Revision: 19, Status: Authorised
Transferring a veterinary marketing authorisation
Q&A clinic on Product Management Service (PMS) Product User Interface - 20 June 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 June 2024, 15:00 (CEST) to 20 June 2024, 15:30 (CEST)
Q&A clinic on Product Management Service (PMS) Product User Interface - 13 June 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 June 2024, 15:00 (CEST) to 13 June 2024, 15:30 (CEST)
EMA public launch event on the guideline on good pharmacovigilance practices Module XVI on risk minimisation measures and its Addendum II, Online, from 11 September 2024, 10:00 (CEST) to 11 September 2024, 11:30 (CEST)
Dates of 2025 Scientific Advice Working Party (SAWP) meetings and submission deadlines scientific advice, protocol assistance, qualification of biomarkers and EMA/EUnetHTA parallel consultation requests
EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna
Presentation - International collaboration to facilitate medicines availability global assessment / inspection pathways
Presentation - Update on Network Portfolio activities